G1 Therapeutics, Inc. (GTHX)
USD 7.16
(0.14%)
USD 7.16
(0.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -38.33 Million | -128.62 Million | -132.1 Million | -83.74 Million | -99.57 Million | -74.3 Million |
| Net Income | -47.96 Million | -147.55 Million | -148.35 Million | -99.25 Million | -122.44 Million | -85.28 Million |
| Depreciation & Amortization | 513 Thousand | 530 Thousand | 469 Thousand | 582 Thousand | 356 Thousand | 175 Thousand |
| Deferred income taxes | 1.22 Million | - | 590 Thousand | -545 Thousand | -16.91 Million | - |
| Stock-based compensation | 14.51 Million | 20.58 Million | 22.31 Million | 18.77 Million | 16.44 Million | 10.22 Million |
| Change in working capital | -5.2 Million | -5.3 Million | -8.83 Million | -4.07 Million | 6.07 Million | 573 Thousand |
| Other non-cash items | -1.41 Million | 3.12 Million | 1.7 Million | 781 Thousand | 16.91 Million | 8000.00 |
| Investing Cash Flow | 2.81 Million | -50.52 Million | - | 152 Thousand | -2.71 Million | -709 Thousand |
| Investments in PPE | - | -506 Thousand | - | - | -2.71 Million | -709 Thousand |
| Acquisitions | - | 50.02 Million | - | 152 Thousand | - | - |
| Investment purchases | -124.69 Million | -65.02 Million | - | - | - | - |
| Sales/Maturities of investments | 127.5 Million | 15 Million | - | - | - | - |
| Other Investing Activities | 2.81 Million | -50.02 Million | - | 152 Thousand | - | - |
| Financing Cash Flow | -26.91 Million | 52.49 Million | 145.86 Million | 21.68 Million | 2.7 Million | 340.49 Million |
| Debt repayment | -26.68 Million | - | -55 Million | -19.38 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -224 Thousand | 52.38 Million | 92.22 Million | 2.3 Million | 2.7 Million | 340.49 Million |
| Other Financing Activities | -281 Thousand | 112 Thousand | 90.86 Million | 38.76 Million | 2.7 Million | 340.49 Million |
| Accounts receivables | -1.59 Million | -5.4 Million | -5.45 Million | -237 Thousand | - | - |
| Accounts payables | -3.37 Million | 4.42 Million | -675 Thousand | -244 Thousand | 248 Thousand | -1 Million |
| Inventory | 3.73 Million | -12.7 Million | -3.47 Million | -3.83 Million | - | - |
| Other working capital | -3.97 Million | 8.38 Million | 759 Thousand | 237 Thousand | 5.82 Million | 1.57 Million |
| Cash at beginning of period | 94.65 Million | 221.56 Million | 207.8 Million | 269.7 Million | 369.29 Million | 103.81 Million |
| Cash at end of period | 32.28 Million | 94.9 Million | 221.56 Million | 207.8 Million | 269.7 Million | 369.29 Million |
| Capital Expenditure | - | -506 Thousand | - | - | -2.71 Million | -709 Thousand |
| Effect of forex changes on cash | 63 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -62.37 Million | -126.65 Million | 13.75 Million | -61.9 Million | -99.58 Million | 265.47 Million |
| Free Cash Flow | -38.33 Million | -129.12 Million | -132.1 Million | -83.74 Million | -102.28 Million | -75.01 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.46 Million | -10.21 Million | -10.87 Million | -47.96 Million | -18.2 Million | 8.71 Million |
| Depreciation & Amortization | 121 Thousand | 120 Thousand | 124 Thousand | 513 Thousand | 127 Thousand | 130 Thousand |
| Deferred income taxes | - | - | 10.25 Million | 1.22 Million | -9.67 Million | -584 Thousand |
| Stock-based compensation | 2.09 Million | 2.54 Million | 3.2 Million | 14.51 Million | 3.65 Million | 3.81 Million |
| Change in working capital | -2.64 Million | -1.49 Million | -5.02 Million | -5.2 Million | 4.18 Million | 1.97 Million |
| Other non-cash items | 4.99 Million | 1.33 Million | -10.48 Million | -1.41 Million | 9.33 Million | 43 Thousand |
| Investing Cash Flow | 229 Thousand | 5.28 Million | -7.64 Million | 2.81 Million | 7.2 Million | 346 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | 1000.00 | - | - | - | - |
| Investment purchases | -36.47 Million | -17.21 Million | -47.14 Million | -124.69 Million | -12.29 Million | -40.15 Million |
| Sales/Maturities of investments | 36.7 Million | 22.5 Million | 39.5 Million | 127.5 Million | 19.5 Million | 40.5 Million |
| Other Investing Activities | - | 1000.00 | -7.64 Million | 2.81 Million | 7.2 Million | 346 Thousand |
| Financing Cash Flow | 232 Thousand | -8.72 Million | 34 Thousand | -26.91 Million | 22 Thousand | -26.75 Million |
| Debt repayment | -553 Thousand | -8.74 Million | -1000.00 | -26.68 Million | -1000.00 | -26.68 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 232 Thousand | 26 Thousand | 33 Thousand | -224 Thousand | 23 Thousand | -66 Thousand |
| Other Financing Activities | - | -8.72 Million | 2000.00 | -281 Thousand | 22 Thousand | -66 Thousand |
| Accounts receivables | -1.65 Million | 1.03 Million | -3.42 Million | -1.59 Million | 3.9 Million | 2.85 Million |
| Accounts payables | 458 Thousand | 679 Thousand | -2.32 Million | -3.37 Million | 970 Thousand | 307 Thousand |
| Inventory | -835 Thousand | -106 Thousand | 1.04 Million | 3.73 Million | 2.1 Million | -57 Thousand |
| Other working capital | -611 Thousand | -3.1 Million | -325 Thousand | -3.97 Million | -2.8 Million | -1.12 Million |
| Cash at beginning of period | 19.95 Million | 32.28 Million | 52.68 Million | 94.65 Million | 56.22 Million | 68.55 Million |
| Cash at end of period | 15.13 Million | 19.95 Million | 32.28 Million | 32.28 Million | 52.87 Million | 56.22 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | 63 Thousand | - | - |
| Net cash flow / Change in cash | -4.81 Million | -12.33 Million | -20.4 Million | -62.37 Million | -3.35 Million | -12.32 Million |
| Free Cash Flow | -5.27 Million | -8.89 Million | -12.79 Million | -38.33 Million | -10.57 Million | 14.08 Million |
AGRUF
6H90
002181
6396
6732
ONXYY